Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates

Anxiety and Depression

Maintenance or Discontinuation of Antidepressants in Primary Care

N Engl J Med

Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R, Kendrick T, Kessler D, Mangin D, King M, Lanham P, Moore M, Nazareth I, Wiles N, Bacon F, Bird M, Brabyn S, Burns A, Clarke CS, Hunt A, Pervin J, Lewis G

doi: 10.1056/NEJMoa2106356

Aging and Cognitive Functions

Efficacy of Serotonergic Antidepressant Treatment for the Neuropsychiatric Symptoms and Agitation in Dementia: A Systematic Review and Meta-analysis

Ageing Res Rev

Hsu TW, Stubbs B, Liang CS, Chen TY, Yeh TC, Pan CC, Chu CS

doi: 10.1016/j.arr.2021.101362

Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review

JAMA Neurol.

Roulis E, Hyland C, Flower R, Gassner C, Jung HH, Frey BM

doi: 10.1001/

Anxiety and Depression

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study

Lancet Psychiatry.

Agger JL, Schröder A, Gormsen LK, Jensen JS, Jensen TS, Fink PK

doi: 10.1016/

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial

JAMA.

Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S; and the VAST-D Investigators, Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB 3rd, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT

doi: 10.1001/jama.2017.8036.

Anxiety and Depression

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis

Lancet Psychiatry.

Gueorguieva R, Chekroud AM, Krystal JH

doi: 10.1016/

Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome

Neurology.

Singhal AB, Topcuoglu MA

doi: 10.1212/

Neonatal Abstinence Syndrome.

N Engl J Med.

McQueen K, Murphy-Oikonen J

doi: 10.1056/NEJMra1600879.

Aging and Cognitive FunctionsAnxiety and DepressionBipolar DisorderPsychosis and Schizophrenia

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial

Lancet Psychiatry.

Bockting CLH, Klein NS, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Buskens E, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H

doi: 10.1016/

Related content

Maintenance or Discontinuation of Antidepressants in Primary Care

Efficacy of Serotonergic Antidepressant Treatment for the Neuropsychiatric Symptoms and Agitation in Dementia: A Systematic Review and Meta-analysis

Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis

Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome

Neonatal Abstinence Syndrome.

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial